This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Teva Pharmaceuticals International Gmbh, Assia Chemical Industries Ltd.. Active years: 2020-2025.
Company Filing History:
2 out of 54 
1 out of 40 Years Active: 2020-2025
Title: Martin Valik: Innovator in Pharmaceutical Sciences
Introduction
Martin Valik is a notable inventor based in Male Hostice, Czech Republic. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of solid-state forms of Ixazomib Citrate. With a total of 3 patents to his name, Valik's work has had a meaningful impact on drug formulation and delivery.
Latest Patents
Valik's latest patents include innovative formulations of Ixazomib Citrate. The first patent encompasses solid-state forms of Ixazomib Citrate and pharmaceutical compositions thereof. Additionally, it discloses processes for the preparation of Ixazomib Citrate. The second patent reiterates similar advancements in solid-state forms of Ixazomib Citrate, further emphasizing the importance of this compound in pharmaceutical applications.
Career Highlights
Throughout his career, Martin Valik has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Teva Pharmaceuticals International GmbH and Assia Chemical Industries Ltd. His experience in these organizations has allowed him to refine his expertise in drug development and formulation.
Collaborations
Valik has collaborated with several professionals in his field, including Roman Gabriel and Pavel Vraspir. These collaborations have contributed to the advancement of his research and the successful development of his patented innovations.
Conclusion
Martin Valik stands out as an influential inventor in the pharmaceutical sector, with a focus on solid-state drug formulations. His contributions through patents and collaborations highlight his commitment to advancing pharmaceutical sciences.